Home | Welcome to Contract Pharma   
Last Updated Saturday, May 23 2015


Repligen Expands Facility

By Gil Roth

Published November 1, 2013
Related Searches: Development Biopharma Manufacturing GMP
Repligen Corp. has completed a 9,000-sq.-ft. expansion of its manufacturing facilities at its Waltham, MA headquarters to meet growth in demand for its bioprocessing products and to ensure that the quality, capacity and support needs of its customers continue to be met.

A dedicated production suite more than doubles capacity for the Company's OPUS line of pre-packed chromatography columns, with cleanrooms built to ISO 7 specifications providing an appropriately controlled environment to satisfy the GMP standards of the company's biopharma customers.

"This expansion will enable us to meet the critical needs of our customers for quality and timely delivery," said Walter C. Herlihy, Ph.D., president and chief executive officer of Repligen. "The new cleanroom suite enables us to produce OPUS columns under the highest quality standard demanded by biopharmaceutical manufacturers."

The facility expansion also triples warehouse space and includes dedicated purification and fermentation laboratories for optimization of existing manufacturing processes, new product development and applications support. An additional 17,000 sq. ft. is reserved for future expansion of the same facility.

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On